IT201700109459A1 - Metodo per effettuare prognosi del cancro della mammella, kit ed uso di questi - Google Patents

Metodo per effettuare prognosi del cancro della mammella, kit ed uso di questi

Info

Publication number
IT201700109459A1
IT201700109459A1 IT102017000109459A IT201700109459A IT201700109459A1 IT 201700109459 A1 IT201700109459 A1 IT 201700109459A1 IT 102017000109459 A IT102017000109459 A IT 102017000109459A IT 201700109459 A IT201700109459 A IT 201700109459A IT 201700109459 A1 IT201700109459 A1 IT 201700109459A1
Authority
IT
Italy
Prior art keywords
kits
breast cancer
prognosis
perform
perform prognosis
Prior art date
Application number
IT102017000109459A
Other languages
English (en)
Inventor
Antonio Rulli
Angelo Sidoni
Original Assignee
Univ Degli Studi Di Perugia
Lega Italiana Per La Lotta Contro I Tumori Lilt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Degli Studi Di Perugia, Lega Italiana Per La Lotta Contro I Tumori Lilt filed Critical Univ Degli Studi Di Perugia
Priority to IT102017000109459A priority Critical patent/IT201700109459A1/it
Publication of IT201700109459A1 publication Critical patent/IT201700109459A1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
IT102017000109459A 2017-09-29 2017-09-29 Metodo per effettuare prognosi del cancro della mammella, kit ed uso di questi IT201700109459A1 (it)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT102017000109459A IT201700109459A1 (it) 2017-09-29 2017-09-29 Metodo per effettuare prognosi del cancro della mammella, kit ed uso di questi

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000109459A IT201700109459A1 (it) 2017-09-29 2017-09-29 Metodo per effettuare prognosi del cancro della mammella, kit ed uso di questi

Publications (1)

Publication Number Publication Date
IT201700109459A1 true IT201700109459A1 (it) 2019-03-29

Family

ID=61024941

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102017000109459A IT201700109459A1 (it) 2017-09-29 2017-09-29 Metodo per effettuare prognosi del cancro della mammella, kit ed uso di questi

Country Status (1)

Country Link
IT (1) IT201700109459A1 (it)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202100023900A1 (it) 2021-09-16 2023-03-16 Univ Degli Studi Di Perugia Metodo per la diagnosi e la prognosi di tumori

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005076005A2 (en) * 2004-01-30 2005-08-18 Medizinische Universität Wien A method for classifying a tumor cell sample based upon differential expression of at least two genes
WO2005083429A2 (en) * 2004-02-20 2005-09-09 Veridex, Llc Breast cancer prognostics
WO2009158143A1 (en) * 2008-05-30 2009-12-30 The University Of North Carolina At Chapel Hill Gene expression profiles to predict breast cancer outcomes
EP2298936A1 (en) * 2008-07-02 2011-03-23 Centro De Investigaciones Energeticas Medioambientales Y Tecnologicas (C.I.E.M.A.T.) Genomic fingerprint of mammary cancer

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005076005A2 (en) * 2004-01-30 2005-08-18 Medizinische Universität Wien A method for classifying a tumor cell sample based upon differential expression of at least two genes
WO2005083429A2 (en) * 2004-02-20 2005-09-09 Veridex, Llc Breast cancer prognostics
WO2009158143A1 (en) * 2008-05-30 2009-12-30 The University Of North Carolina At Chapel Hill Gene expression profiles to predict breast cancer outcomes
EP2298936A1 (en) * 2008-07-02 2011-03-23 Centro De Investigaciones Energeticas Medioambientales Y Tecnologicas (C.I.E.M.A.T.) Genomic fingerprint of mammary cancer

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
J PANSE ET AL: "Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients", BRITISH JOURNAL OF CANCER, vol. 99, no. 6, 16 September 2008 (2008-09-16), pages 930 - 938, XP055061916, ISSN: 0007-0920, DOI: 10.1038/sj.bjc.6604621 *
KATHERINE E. VARLEY ET AL: "Recurrent read-through fusion transcripts in breast cancer", BREAST CANCER RESEARCH AND TREATMENT., vol. 146, no. 2, 15 June 2014 (2014-06-15), US, pages 287 - 297, XP055457370, ISSN: 0167-6806, DOI: 10.1007/s10549-014-3019-2 *
VALENTINA MIANO ET AL: "Luminal long non-coding RNAs regulated by estrogen receptor alpha in a ligand-independent manner show functional roles in breast cancer", ONCOTARGET, vol. 7, no. 3, 19 January 2016 (2016-01-19), XP055457171, DOI: 10.18632/oncotarget.6420 *
YASHAR S. NIKNAFS ET AL: "The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression", NATURE COMMUNICATIONS, vol. 7, 26 September 2016 (2016-09-26), pages 12791, XP055457168, DOI: 10.1038/ncomms12791 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202100023900A1 (it) 2021-09-16 2023-03-16 Univ Degli Studi Di Perugia Metodo per la diagnosi e la prognosi di tumori
WO2023041544A1 (en) 2021-09-16 2023-03-23 Università degli Studi di Perugia Method for the diagnosis and prognosis of tumours

Similar Documents

Publication Publication Date Title
IL260400B (en) Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies
IL269810A (en) Combinatorial cancer immunotherapy
IL257331A (en) Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
IL280039A (en) Compositions and methods related to diagnosis of prostate cancer
MX374788B (es) Anticuerpos anti-tim3 y metodos de uso.
MX386587B (es) ANTICUERPOS ANTI-CD79b Y MÉTODOS DE USO.
MA47811A (fr) Kit comprenant un conjugué anticorps-médicament igf-1r et son utilisation pour le traitement du cancer
PL3319985T3 (pl) Nowe peptydy i kombinacja peptydów do stosowania w immunoterapii względem raka przełyku i innych rodzajów raka
BR112017017700A2 (pt) métodos, composições e kits para tratamento do câncer
MX372675B (es) Anticuerpos anti-jagged1 y metodos de uso.
IL281355B (en) Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm
EP3781188A4 (en) ADOPTIVE CELL THERAPY
BR112016017112A2 (pt) Composições de apilimod e métodos de uso das mesmas
BR112018010279A2 (pt) novos anticorpos anti-emr2 e métodos de uso
PT3200582T (pt) Composições, kits e métodos para induzir citorresistência adquirida com utilização de indutores de proteínas de stress
EP3394620C0 (en) BLADDER CANCER BIOMARKER PROTEINS
PL3490560T3 (pl) Niraparyb do stosowania w sposobie leczenia nowotworu prostaty
IL272487B (en) Antibodies useful in cancer diagnosis
HUE054864T2 (hu) In vitro módszer tüdõrák diagnosztizálására
BR112018012884A2 (pt) novos anticorpos anti-mmp16 e métodos de uso
BR112018012883A2 (pt) novos anticorpos anti-upk1b e métodos de uso
IL308399A (en) Methods of treating cancer
IL281600A (en) Methods of treating cancer
PL3317300T3 (pl) Dwuswoiste przeciwciała do zastosowania do immunoterapii nowotworu
EP3456354A4 (en) NEW AGENTS AGAINST MALIGN TUMORS BASED ON THE SPECIFICITY OF CANCER CELL METABOLISM